FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137084377> ?p ?o ?g. }

• W2137084377 endingPage "812" @default.
• W2137084377 startingPage "806" @default.
• W2137084377 abstract "JDDG: Journal der Deutschen Dermatologischen GesellschaftVolume 7, Issue 9 p. 806-812 Use of high-dose immunoglobulins in dermatology Alexander Enk, Alexander EnkSearch for more papers by this authorGerhard Fierlbeck, Gerhard FierlbeckSearch for more papers by this authorLars French, Lars FrenchSearch for more papers by this authorMichael Hertl, Michael HertlSearch for more papers by this authorGerald Messer, Gerald MesserSearch for more papers by this authorMichael Meurer, Michael MeurerSearch for more papers by this authorKerstin Steinbrink, Kerstin SteinbrinkSearch for more papers by this authorGeorg Stingl, Georg StinglSearch for more papers by this authorBeatrice Volc-Platzer, Beatrice Volc-PlatzerSearch for more papers by this authorDetlef Zillikens, Detlef ZillikensSearch for more papers by this author Alexander Enk, Alexander EnkSearch for more papers by this authorGerhard Fierlbeck, Gerhard FierlbeckSearch for more papers by this authorLars French, Lars FrenchSearch for more papers by this authorMichael Hertl, Michael HertlSearch for more papers by this authorGerald Messer, Gerald MesserSearch for more papers by this authorMichael Meurer, Michael MeurerSearch for more papers by this authorKerstin Steinbrink, Kerstin SteinbrinkSearch for more papers by this authorGeorg Stingl, Georg StinglSearch for more papers by this authorBeatrice Volc-Platzer, Beatrice Volc-PlatzerSearch for more papers by this authorDetlef Zillikens, Detlef ZillikensSearch for more papers by this author First published: 26 August 2009 https://doi.org/10.1111/j.1610-0387.2009.07118.xCitations: 11 Prof. Dr. Alexander Enk Director of the Department of DermatologyUniversity of Heidelberg Voßstraße 2D-69115 Heidelberg, Germany E-mail: [email protected] Section EditorProf. Dr. Hans Christian Korting,München Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Amato AA, Barohn RJ, Jackson CE, Pappert EJ, Sahenk Z, Kissel JT. Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology 1994; 44: 1516–8. 2 Aries PM, Hellmich B, Gross WL. Intravenous immunglobulin therapy in vasculitis. Clin Rev All Immunol 2005; 29: 237–245. 3 Cherin P, Piette JC, Wechsler B, Bletry O, Ziza JM, Laraki R, et al . Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 1994; 21: 1092–7. 4 Choy EHS, Hoogendijk JE, Lecky B, Winer JB. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Art. No.: CD003643. 5 Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001; 56: 323–7. 6 Dalakas MC. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol 1995; 15: 70S–5S. 7 Enk A, Hertl M, Messer G, Meurer M, Rentz E, Zillikens D. The use of high dose intravenous immunoglobulins in dermatology. J Dtsch Dermatol Ges 2003 Mar; 1(3): 183–90. German. 8 Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunzicker T, Saurat JH, Tschopp J, French L. Inhibition of TEN by blockade of CD95 with human IVIg. Science 1998 Oct; 282: 490–493. 9 Mittmann N, Chan BC, Knowles S, Shear NH. IVIg for the treatment of toxic epidermal necrolysis. Skin therapy Lett 2007 Feb; 12(1): 7–9. 10 Jolles S, Hughes J, Whittaker S. Der-matological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998 Jan; 134(1): 80–6. 11 Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol 2006 Apr; 6(4): 579–91. 2005 Dec 13. Review. 12 Karim A, Lawlor F, Black MM. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 2004 May; 29(3): 317–8. 13 Körber A, Franckson T, Grabbe S, Dissemond J. (2007) Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin. Journal of the European Academy of Dermatology and Venereology 2007; 21(4), 553–554. 14 Kukova G, Bruch-Gerharz D, Gensch K, Ruzicka T, Reifenberger J. Skleromyxödem. Der Hautarzt 2006; 57(4), 326. 15 Levy Y, George J, Fabbrizzi F, Rotman P, Paz Y, Shoenfeld Y. Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins. Southern Medical Journal 1999; 92(4): 412–414. 16 Levy Y, Langevitz P, Nacci F, Righi A, Conforti L, Generini S, Shoenfeld Y. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open label study. Arthritis Rheum 2004; 1005–7. 17 Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 2002 Sep; 147(3): 518–22. 18 Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007 Feb; 56(2): 181–200. 19 Prins C, Gelfand E W, French LE. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol 2007; 87: 206–18. 20 Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL. Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunglobulin. Clin Exp Immunol 1995; 101: 2–7. 21 Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis-four year review of nine cases. Arch Dis Child 1995; 72: 25–8. 22 Schanz S, Ulmer A, Fierlbeck G. Intravenous immunglobulin in livedo vasculitis: A new treatment option? A Am Acad Dermatol 2003; 49(3): 555–556. 23 Shoenfeld Y, Katz U. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients. Autoimmunity 2005; 38(2): 123–137. 24 Topf S, Simon M jr., Schell H, Lüftl M. Deutliche Besserung eines Skleromyxödem Arndt-Gottron durch hoch dosierte intravenöse Immunglobuline. Der Hautarzt 2006. 25 Toubi E, Kessel A, Shoenfeld Y. High dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Hum. Immunol 2005; 66: 395–402. Citing Literature Volume7, Issue9September 2009Pages 806-812 ReferencesRelatedInformation" @default.
• W2137084377 created "2016-06-24" @default.
• W2137084377 creator A5034272199 @default.
• W2137084377 creator A5041627641 @default.
• W2137084377 creator A5044053537 @default.
• W2137084377 creator A5045400169 @default.
• W2137084377 creator A5051230998 @default.
• W2137084377 creator A5075254922 @default.
• W2137084377 creator A5077469980 @default.
• W2137084377 creator A5084788512 @default.
• W2137084377 creator A5090252753 @default.
• W2137084377 creator A5090549024 @default.
• W2137084377 date "2009-08-26" @default.
• W2137084377 modified "2023-10-18" @default.
• W2137084377 title "Use of high-dose immunoglobulins in dermatology" @default.
• W2137084377 cites W149167874 @default.
• W2137084377 cites W1505546427 @default.
• W2137084377 cites W1985693809 @default.
• W2137084377 cites W1989954587 @default.
• W2137084377 cites W1998761610 @default.
• W2137084377 cites W2002702812 @default.
• W2137084377 cites W2006587412 @default.
• W2137084377 cites W2032527273 @default.
• W2137084377 cites W2036688442 @default.
• W2137084377 cites W2055737653 @default.
• W2137084377 cites W2056105141 @default.
• W2137084377 cites W2074203661 @default.
• W2137084377 cites W2075073120 @default.
• W2137084377 cites W2088745086 @default.
• W2137084377 cites W2088858588 @default.
• W2137084377 cites W2106003287 @default.
• W2137084377 cites W2131943685 @default.
• W2137084377 cites W2148001909 @default.
• W2137084377 cites W2419670615 @default.
• W2137084377 cites W3116890861 @default.
• W2137084377 cites W3191863599 @default.
• W2137084377 doi "https://doi.org/10.1111/j.1610-0387.2009.07118.x" @default.
• W2137084377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19624804" @default.
• W2137084377 hasPublicationYear "2009" @default.
• W2137084377 type Work @default.
• W2137084377 sameAs 2137084377 @default.
• W2137084377 citedByCount "6" @default.
• W2137084377 countsByYear W21370843772012 @default.
• W2137084377 countsByYear W21370843772015 @default.
• W2137084377 crossrefType "journal-article" @default.
• W2137084377 hasAuthorship W2137084377A5034272199 @default.
• W2137084377 hasAuthorship W2137084377A5041627641 @default.
• W2137084377 hasAuthorship W2137084377A5044053537 @default.
• W2137084377 hasAuthorship W2137084377A5045400169 @default.
• W2137084377 hasAuthorship W2137084377A5051230998 @default.
• W2137084377 hasAuthorship W2137084377A5075254922 @default.
• W2137084377 hasAuthorship W2137084377A5077469980 @default.
• W2137084377 hasAuthorship W2137084377A5084788512 @default.
• W2137084377 hasAuthorship W2137084377A5090252753 @default.
• W2137084377 hasAuthorship W2137084377A5090549024 @default.
• W2137084377 hasConcept C161191863 @default.
• W2137084377 hasConcept C41008148 @default.
• W2137084377 hasConcept C52119013 @default.
• W2137084377 hasConcept C71924100 @default.
• W2137084377 hasConcept C74916050 @default.
• W2137084377 hasConcept C95457728 @default.
• W2137084377 hasConceptScore W2137084377C161191863 @default.
• W2137084377 hasConceptScore W2137084377C41008148 @default.
• W2137084377 hasConceptScore W2137084377C52119013 @default.
• W2137084377 hasConceptScore W2137084377C71924100 @default.
• W2137084377 hasConceptScore W2137084377C74916050 @default.
• W2137084377 hasConceptScore W2137084377C95457728 @default.
• W2137084377 hasIssue "9" @default.
• W2137084377 hasLocation W21370843771 @default.
• W2137084377 hasLocation W21370843772 @default.
• W2137084377 hasOpenAccess W2137084377 @default.
• W2137084377 hasPrimaryLocation W21370843771 @default.
• W2137084377 hasRelatedWork W1506200166 @default.
• W2137084377 hasRelatedWork W1995515455 @default.
• W2137084377 hasRelatedWork W2048182022 @default.
• W2137084377 hasRelatedWork W2080531066 @default.
• W2137084377 hasRelatedWork W2604872355 @default.
• W2137084377 hasRelatedWork W2748952813 @default.
• W2137084377 hasRelatedWork W2899084033 @default.
• W2137084377 hasRelatedWork W3031052312 @default.
• W2137084377 hasRelatedWork W3032375762 @default.
• W2137084377 hasRelatedWork W3108674512 @default.
• W2137084377 hasVolume "7" @default.
• W2137084377 isParatext "false" @default.
• W2137084377 isRetracted "false" @default.
• W2137084377 magId "2137084377" @default.
• W2137084377 workType "article" @default.